ACM
COGT icon

ADAR1 Capital Management’s Cogent Biosciences COGT Stock Holding History

ADAR1 Capital Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$472K Buy
+12,200
New +$427K 0.02% 216

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ADAR1 Capital Management's COGT Position: Q2 2026 in Review

ADAR1 Capital Management opened a new position in Cogent Biosciences (COGT) in Q2 2026: 12,200 shares worth $472K. The stake represents 0.02% of the portfolio and ranks #216 among its holdings.

322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • ADAR1 Capital Management held 12,200 shares of Cogent Biosciences worth $472K as of Q2 2026.
  • Cogent Biosciences was a new ADAR1 Capital Management position in Q2 2026.
  • Cogent Biosciences made up 0.02% of ADAR1 Capital Management's portfolio in Q2 2026, its #216 holding.
  • 322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.